| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib
|
Chen, Kaiyan
|
|
|
22 |
1 |
p. e1-e4
|
artikel
|
| 2 |
A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non–small-cell Lung Cancer
|
Tanaka, Hisashi
|
|
|
22 |
1 |
p. 42-48
|
artikel
|
| 3 |
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non–small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design
|
Passiglia, Francesco
|
|
|
22 |
1 |
p. e63-e66
|
artikel
|
| 4 |
A Rare Presentation of Primary Pulmonary Synovial Sarcoma
|
Emerel, Leonid
|
|
|
22 |
1 |
p. e48-e50
|
artikel
|
| 5 |
Clinical and Imaging Features of Non–Small-Cell Lung Cancer in Young Patients
|
Garrana, Sherief H.
|
|
|
22 |
1 |
p. 23-31
|
artikel
|
| 6 |
Clinical Characteristics, Treatments, and Concurrent Mutations in Non–Small Cell Lung Cancer Patients With NF1 Mutations
|
Bowman, Lee
|
|
|
22 |
1 |
p. 32-41.e1
|
artikel
|
| 7 |
Development of Bronchopleural Fistula After Durvalumab Consolidation for Stage III Non–Small-Cell Lung Cancer
|
Darwin, Alicia
|
|
|
22 |
1 |
p. e18-e24
|
artikel
|
| 8 |
Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of “Blast Metastasis”
|
Ekeke, Chigozirim N.
|
|
|
22 |
1 |
p. e132-e135
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
22 |
1 |
p. A1
|
artikel
|
| 10 |
Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC
|
Steber, Cole R.
|
|
|
22 |
1 |
p. e122-e131
|
artikel
|
| 11 |
Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non–Small-Cell Lung Cancer
|
Jahanzeb, Mohammad
|
|
|
22 |
1 |
p. 49-57
|
artikel
|
| 12 |
Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation
|
Urbán, László
|
|
|
22 |
1 |
p. e112-e115
|
artikel
|
| 13 |
Management of Non–Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study
|
Chen, Xin-ru
|
|
|
22 |
1 |
p. e25-e34
|
artikel
|
| 14 |
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial
|
Spigel, David R.
|
|
|
22 |
1 |
p. 6-15.e4
|
artikel
|
| 15 |
Next Generation Sequencing of Advanced Non–Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival
|
Al-Ahmadi, Asrar
|
|
|
22 |
1 |
p. 16-22.e1
|
artikel
|
| 16 |
NTRK Fusion-positive Non–small-cell Lung Cancer: The Diagnosis and Targeted Therapy
|
Haratake, Naoki
|
|
|
22 |
1 |
p. 1-5
|
artikel
|
| 17 |
Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy
|
Sun, Lova
|
|
|
22 |
1 |
p. 58-66.e3
|
artikel
|
| 18 |
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design
|
Riess, Jonathan W.
|
|
|
22 |
1 |
p. 67-70
|
artikel
|
| 19 |
PLEKHH2-ALK: A Novel In-frame Fusion With Durable Response to Alectinib: Utilizing RNA Sequencing in Search for Hidden Gene Fusions Susceptible to Targeted Therapy
|
Nagasaka, Misako
|
|
|
22 |
1 |
p. e51-e53
|
artikel
|
| 20 |
Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non–Small-Cell Lung Cancer in the United States
|
Stenehjem, David D.
|
|
|
22 |
1 |
p. e35-e47
|
artikel
|
| 21 |
Role of Antiangiogenic Agents Combined With EGFR Tyrosine Kinase Inhibitors in Treatment-naive Lung Cancer: A Meta-Analysis
|
Deng, Zhujun
|
|
|
22 |
1 |
p. e70-e83
|
artikel
|
| 22 |
Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non–small-cell Lung Cancer
|
Zhu, Yan-juan
|
|
|
22 |
1 |
p. e98-e111
|
artikel
|
| 23 |
Successful Switch to Vemurafenib Plus Cobimetinib After Dabrafenib Plus Trametinib Toxicity in BRAF V600E-Mutant Metastatic Non–Small-Cell Lung Cancer
|
Chic, Nuria
|
|
|
22 |
1 |
p. e54-e56
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
22 |
1 |
p. A3-A4, A6-A8
|
artikel
|
| 25 |
The Effects of Time to Treatment Initiation for Patients With Non–small-cell Lung Cancer in the United States
|
Cushman, Taylor R.
|
|
|
22 |
1 |
p. e84-e97
|
artikel
|
| 26 |
The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
|
Oh, Michael S.
|
|
|
22 |
1 |
p. e57-e62
|
artikel
|
| 27 |
The Role of Postoperative Radiation Therapy for pN2 Non–small-cell Lung Cancer
|
Mankuzhy, Nikhil P.
|
|
|
22 |
1 |
p. e5-e17
|
artikel
|
| 28 |
Three Primary Tumors Including EGFR-mutated Non–Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome
|
Gower, Arjan
|
|
|
22 |
1 |
p. e116-e121
|
artikel
|
| 29 |
Tocilizumab for COVID-19 Pneumonia in a Patient With Non–Small-cell Lung Cancer Treated With Chemoimmunotherapy
|
Bonomi, Maria
|
|
|
22 |
1 |
p. e67-e69
|
artikel
|
Tijdschrift beschrijving